Euroapi S.A. (ENXTPA: EAPI)
Health Care · Pharmaceuticals · FR
€0.98
+0.31% today · -68.9% 1Y
Euroapi S.A. (ENXTPA: EAPI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $109.18M and employs 3,000 people.
Over the last twelve months the share price has lost 68.9%, trading between 0.92 and 3.44.
Tweenvest scores Euroapi S.A. across four factors: quality 60/100, value 75/100, growth 29/100. Its strongest factor is value.
EAPI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $109.18M
- Revenue (TTM)
- $907.80M
- P/E
- —
- EPS
- -3.43
- Dividend yield
- —
- Beta (5Y)
- 0.96
- 52-week high
- €3.44
- 52-week low
- €0.92
- Avg volume (3M)
- —
- Shares outstanding
- 95.53M
- Employees
- 3,000
- Next earnings
- —
About Euroapi S.A.
Headquartered in Paris, France, Euroapi SA, founded in 2021, specializes in the research, production, promotion, and delivery of active pharmaceutical ingredients (APIs) and chemical intermediates. These vital components are utilized in the development of both human and animal medical treatments.
- Founded
- 2020
- Listed since
- May 6, 2022
- Exchange
- Euronext Paris
- Currency
- EUR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.